|
【结 构 式】
|
【药物名称】NSC-32122, SOAz 【化学名称】1,3,3,5,5-Pentaziridino-1-thia-2,4,6-triaza-3,5-diphosphorine 1-oxide 【CA登记号】77680-87-6 【 分 子 式 】C10H20N8OP2S 【 分 子 量 】362.3355 |
【开发单位】Otsuka (Originator), Taiho (Originator) 【药理作用】ONCOLYTIC DRUGS |
合成路线1
By reaction of 1,3,3,5,5-pentachloro-1-thia-2,4,6-triaza-3,5-diphosphorine-1-oxide (I) with aziridine (II) in ether.

| 【1】 Van der Huizen, A.A.; Sournies, F.; Labarre, J.F.; Van der Grampel, J.C.; Wiedijk, D.; Jekel, A.P.; Derivatives of cis-NPCl2(NSOCl)2 and (NPCl2)2 NSOCl. Part XVI. The preparation of some aziridino (ethyleneimino) derivatives of (NPCl2)2 NSOX (X=F,Az,Ph) with a potential anticancer activity. Inorg Chim Acta 1981, 53, 4, 169-170. |
| 【2】 Labarre, J.F.; Sournies, F.; Van der Grampel, J.; Van der Huizen, A. (ANVAR (Agence Natl. Valor. Rech.)); Inorganocyclic cpds. usable as medicaments and a process for their preparation. EP 0022407 . |
| 【3】 Blancafort, P.; Castaner, J.; Serradell, M.N.; Hopkins, S.J.; SOAz. Drugs Fut 1983, 8, 7, 605. |
Extended Information